PH151
|
POEMS syndrome: still an enigma?
Hermine O, Frenzel L, Jaccard A.
Oncology (Williston Park). 2013 Dec;27(12):1260, 1262.
|
PH150
|
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial.
Zimmermann H, Choquet S, Moore J, Salles G, Morschhauser F, Lamy T, Jaccard A, Horst HA, Leithäuser M, Dührsen U, Reinke P, Lebranchu Y, Neuhaus R, Lehmkuhl H, Tarella C, Schlattmann P, Riess H, Leblond V, Trappe RU.
Leukemia. 2013 Oct;27(10):2102-2105.
|
PH149
|
Cardiac amyloidosis: Updates in diagnosis and management.
Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A.
Arch Cardiovasc Dis. 2013 Oct;106(10):528-40.
|
PH148
|
Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.
Rizzo D, Lotay A, Gachard N, Marfak I, Faucher JL, Trimoreau F, Guérin E, Bordessoule D, Jaccard A, Feuillard J.
Am J Hematol. 2013 Sep;88(9):747-53
|
PH147
|
RelA and RelB cross-talk and function in epstein-barr virus transformed B-cells.
Chanut A, Duguet F, Marfak A, David A, Petit B, Parrens M, Durand-Panteix S, Boulin-Deveza M, Gachard N, Youlyouz-Marfak I, Bordessoule D, Feuillard J, Faumont N.
Leukemia. 2013 Sep 23.
|
PH146
|
Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.
Rizzo D, Lotay A, Gachard N, Marfak I, Faucher JL, Trimoreau F, Guérin E, Bordessoule D, Jaccard A, Feuillard J.
Am J Hematol. 2013 Sep;88(9):747-53.
|
PH145
|
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Santini V, Schemenau J, Levis A, Balleari E, Sapena R, Adès L, Guerci A, Beyne-Rauzy O, Gourin MP, Cheze S, Stamatoullas A, Sanna A, Gioia D, Cametti G, Ferrero D, Raffoux E, Rose C, Poloni A, Prebet T, Legros L, Natarajan-Amé S, Fenaux P, Germing U, Dreyfus F, Park S. Blood. 2013 Sep 26;122(13):2286-8.
|
PH144
|
Outcome of older patients with acute myeloid leukemia in first relapse.
Sarkozy C, Gardin C, Gachard N, Merabet F, Turlure P, Malfuson JV, Pautas C, Micol JB, Thomas X, Quesnel B, Celli-Lebras K, Preudhomme C, Terré C, Fenaux P, Chevret S, Castaigne S, Dombret H.
Am J Hematol. 2013 Sep;88(9):758-64.
|
PH143
|
Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant.
Van Den Neste E, Casasnovas O, André M, Touati M, Senecal D, Edeline V, Stamatoullas A, Fornecker L, Deau B, Gastinne T, Reman O, Gaillard I, Borel C, Brice P, Fermé C.
Haematologica. 2013 Aug;98(8):1185-95.
|
PH142
|
Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.
Pascal L, Beyne-Rauzy O, Brechignac S, Marechaux S, Vassilieff D, Ernst O, Berthon C, Gyan E, Gourin MP, Dreyfus F, Fenaux P, Rose C.
Br J Haematol. 2013 Aug;162(3):413-5.
|
PH141
|
Vaccination post hematopoietic stem cell transplantation: Which vaccines and when and, how to vaccinate? An SFGM-TC report.
Rubio MT, Charbonnier A, de Berranger E, Gandemer V, Magro L, Maury S, Sterkers G, Suarez F, Dalle JH, Daguindau E, Galumbrun C, Hermet E, Reman O, Turlure P, Yakoub-Agha I.
Pathol Biol (Paris). 2013 Aug;61(4):139-43.
|
PH140
|
Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report.
Bay JO, Peffault de Latour R, Bruno B, Coiteux V, Guillaume T, Hicheri Y, Paillard C, Suarez F, Turlure P, Alain S, Bulabois CE, Socié G, Bauters F, Yakoub-Agha I.
Pathol Biol (Paris). 2013 Aug;61(4):152-4.
|
PH139
|
Reply to S. Girnius et al.
Palladini G, Dispenzieri A, Gertz M, Kumar S, Wechalekar A, Hawkins PN, Schönland S, Hegenbart U, Comenzo R, Kastritis E, Dimopoulos MA, Jaccard A, Klersy C, Merlini G.
J Clin Oncol. 2013 Jul 20;31(21):2750-1.
|
PH138
|
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents.
Kelaidi C, Park S, Sapena R, Beyne-Rauzy O, Coiteux V, Vey N, Stamatoullas A, Choufi B, Delaunay J, Gourin MP, Cheze S, Ravoet C, Ferrant A, Escoffre-Barbe M, Aljassem L, Raffoux E, Itzykson R, Adès L, Dreyfus F, Fenaux P.
Leukemia. 2013 Jun;27(6):1283-90.
|
PH137
|
Senile systemic amyloidosis: definition, diagnosis, why thinking about?
Damy T, Mohty D, Deux JF, Rosso J, Benhaiem N, Lellouche N, Sabbah L, Guendouz S, Tissot CM, Rappeneau S, Pongas D, Bodez D, Krypciak S, Guellich A, Dubois-Randé JL, Hittinger L, Lefaucheur JP, Jaccard A, Planté-Bordeneuve V.
Presse Med. 2013 Jun;42(6 Pt 1):1003-14
|
PH136
|
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
Bally C, Thépot S, Quesnel B, Vey N, Dreyfus F, Fadlallah J, Turlure P, de Botton S, Dartigeas C, de Renzis B, Itzykson R, Fenaux P, Adès L.
Leuk Res. 2013 Jun;37(6):637-40
|
PH135-b
|
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.
Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center.
Transfusion. 2013 May 27
|
PH135-a
|
High response rate and improved exercise capacity and quality of life with a new regimen of
darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
Kelaidi C, Beyne-Rauzy O, Braun T, Sapena R, Cougoul P, Adès L, Pillard F, Lamberto C, Charniot JC, Guerci A, Choufi B, Stamatoullas A, Slama B, De Renzis B, Ame S, Damaj G, Boyer F,Chaury MP, Legros L, Cheze S, Testu A, Gyan E, Béné MC, Rose C, Dreyfus F, Fenaux P.
Ann Hematol. 2013 May;92(5):621-31
|
PH134
|
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
Ketterer N, Coiffier B, Thieblemont C, Fermé C, Brière J, Casasnovas O, Bologna S, Christian B, Connerotte T, Récher C, Bordessoule D, Fruchart C, Delarue R, Bonnet C, Morschhauser F, Anglaret B, Soussain C, Fabiani B, Tilly H, Haioun C.
Ann Oncol. 2013 Apr;24(4):1032-7.
J Immunother. 2014 Apr;37(3):170-9.
|
PH133
|
T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells: Lessons From a Phase I/II Feasibility and Safety Study.
Gallot G, Vollant S, Saïagh S, Clémenceau B, Vivien R, Cerato E, Bignon JD, Ferrand C, Jaccard A, Vigouroux S, Choquet S, Dalle JH, Frachon I, Bruno B, Mothy M, Mechinaud F, Leblond V, Milpied N, Vié H.
|
PH132
|
Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patients.
Royer B, Merlusca L, Abraham J, Musset L, Haroche J, Choquet S, Leleu X, Sebban C, Decaux O, Galicier L, Roussel M, Recher C, Banos A, Guichard I, Brisseau JM, Godmer P, Hermine O, Deplanque G, Facon T, Asli B, Leblond V, Fermand JP, Marolleau JP,Jaccard A.
Am J Hematol. 2013 Mar;88(3):207-12
|
PH131
|
T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells.
Rizzo D, Bouvier G, Youlyouz-Marfak I, Guerin E, Trimoreau F, Bordessoule D,Jaccard A, Gachard N, Feuillard J.
Cytometry B Clin Cytom. 2013 Mar;84(2):125-32.
|
PH130
|
Design and feasibility of a novel, rapid, and simple fluorescence 26-plex rt-PCR assay for simultaneous detection of 24 fusion transcripts in adult acute myeloid leukemia.
Laforêt MP,Turlure P, Lippert E, Cornillet-Lefebvre P, Pigneux A, Pradeau R, Feuillard J, Gachard N.
J Mol Diagn. 2013 Mar;15(2):186-95.
|
PH129
|
Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.
Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, Gérard L, Lee M, Watier H, Oksenhendler E; DEFI study group.
Clin Exp Immunol. 2013 Feb;171(2):186-94
|
PH128
|
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.
Gardin C, Chevret S, Pautas C, Turlure P, Raffoux E, Thomas X, Quesnel B, de Revel T, de Botton S, Gachard N, Renneville A, Boissel N, Preudhomme C, Terré C, Fenaux P,Bordessoule D, Celli-Lebras K, Castaigne S, Dombret H.
J Clin Oncol. 2013 Jan 20;31(3):321-7.
|
PH127
|
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
Damaj G, Gressin R, Bouabdallah K, Cartron G, Choufi B, Gyan E, Banos A,Jaccard A, Park S, Tournilhac O, Schiano-de Collela JM, Voillat L, Joly B, Le Gouill S, Saad A, Cony-Makhoul P, Vilque JP, Sanhes L, Schmidt-Tanguy A, Bubenheim M, Houot R, Diouf M, Marolleau JP, Béné MC, Martin A, Lamy T.
J Clin Oncol. 2013 Jan 1;31(1):104-10.
|
PH126
|
Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.
Boursiquot JN, Gérard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, Borie R, Viallard JF, Soulas-Sprauel P, Berezne A,Jaccard A, Hachulla E, Haroche J, Schleinitz N, Têtu L, Oksenhendler E; DEFI study group.
J Clin Immunol. 2013 Jan;33(1):84-95.
|
PH125
|
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt MP, de Mascarel A, Merlio JP, Bouabdhalla K, Milpied N, Soubeyran P, Schmitt A, Bordessoule D, Cogné M, Feuillard J.
Leukemia. 2013 Jan;27(1):183-9.
|